Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia-Reference-Cited by-同舟云学术

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia

Published:2024-07-24 Issue:15 Volume:8 Page:3875-3879
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Martín-Sánchez Esperanza¹^ORCID,Blanco Laura¹^ORCID,Kim Peter S.²,Bisht Kamlesh²,Wang Hongfang²^ORCID,Van de Velde Helgi²,Jelinek Tomas¹³,Simoes Catia¹,Prosper Felipe¹^ORCID,San Miguel Jesus F.¹^ORCID,Alfonso Ana¹^ORCID,Bergua Juan⁴^ORCID,Rodríguez-Veiga Rebeca⁵^ORCID,Vives Susana⁶,Martínez-Cuadrón David⁵,Montesinos Pau⁵^ORCID,Paiva Bruno¹^ORCID,Zabaleta Aintzane¹^ORCID

Affiliation:

1. 1Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain

2. 2Sanofi R&D, North America, Cambridge, MA

3. 3Department of Hematooncology, University Hospital of Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

4. 4Hospital San Pedro de Alcántara, Cáceres, Spain

5. 5Hospital Universitario La Fe, Valencia, Spain

6. 6Institut Català d'Oncologia Badalona-Hospital Germans Trias I Pujol, Josep Carreras Research Institute, Badalona, Spain

Publisher

American Society of Hematology

Link

https://ashpublications.org/bloodadvances/article-pdf/8/15/3875/2237924/blooda_adv-2024-013212-main.pdf

Reference25 articles.

1. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish acute leukemia registry;Juliusson;Blood,2009

2. Acute myeloid leukemia;Döhner;N Engl J Med,2015

3. How I treat acute myeloid leukemia in the era of new drugs;DiNardo;Blood,2020

4. How I treat the older patient with acute myeloid leukemia;Ossenkoppele;Blood,2015

5. How I treat refractory and relapsed acute myeloid leukemia;Thol;Blood,2024